Early identification of neutropenic patients at risk of gram-positive bacteraemia and the impact of empirical administration of vancomycin

European Journal of Cancer Part A

Volumn 32, Issue 8, 1996, Pages 1332-1339

  Dompeling, E C ^a   Donnelly, J P ^a   Deresinski, S C ^b   Feld, R ^c   Lane Allman, E F ^d   De Pauw, B E ^a  

^a RADBOUD UNIVERSITY MEDICAL CENTER   (Netherlands)

^b STANFORD UNIVERSITY SCHOOL OF MEDICINE   (United States)

^c PRINCESS MARGARET HOSPITAL   (Canada)

^d GLAXOSMITHKLINE   (United Kingdom)

Author keywords

Ceftazidime; Early identification; Empirical treatment; Fever; Gram positive bacteraemia; Neutropenic patients; Piperacillin tobramycin; Skin and soft tissue infection; Vancomycin

Indexed keywords

CEFTAZIDIME; PIPERACILLIN; TOBRAMYCIN; VANCOMYCIN;

ADULT; ARTICLE; CANCER PATIENT; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DRUG EFFICACY; FEMALE; FEVER; GRAM POSITIVE BACTERIUM; HUMAN; MAJOR CLINICAL STUDY; MALE; MORBIDITY; MULTICENTER STUDY; NEUTROPENIA; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; SKIN INFECTION; SOFT TISSUE INFECTION; TREATMENT OUTCOME;

EID: 0030057185     PISSN: 09598049     EISSN: None     Source Type: Journal    
DOI: 10.1016/0959-8049(96)00050-0     Document Type: Article

References (17)

1. EORTC International Antimicrobial Therapy Cooperative Group. Gram-positive bacteraemia in granulocytopenic cancer patients. Eur J Cancer 1990, 26, 569-574.
2. EORTC International Antimicrobial Therapy Cooperative Group and the National Cancer Institute of Canada-Clinical Trials Group. Vancomycin added to empirical combination antibiotic therapy for fever in granulocytopenic cancer patients. J Infect Dis 1991, 163, 951-958.
3. Press OW, Ramsey PG, Larson EB, Fefer A, Hickman RO. Hickman catheter infections in patients with malignancies. Medicine 1984, 63, 189-200.
4. Cohen J, Donnelly JP, Worsley AM, Catovsky D, Goldman JM, Galton DAG. Septicaemia caused by viridans streptococci in neutropenic patients with leukaemia. Lancet 1983, 2, 1452-1454.
5. Karp JE, Merz WG, Hendricksen C, et al. Oral norfloxacin for prevention of gram-negative bacterial infections in patients with acute leukemia and granulocytopenia. Ann Intern Med 1987, 106, 1-7.
6. Ramphal R, Bolger M, Oblon DJ, et al. Vancomycin is not an essential component of the initial empiric treatment regimen for febrile neutropenic patients receiving ceftazidime: a randomized prospective study. Antimicrob Agents Chemother 1992, 36, 1062-1067.
7. Nováková IRO, Donnelly JP, De Pauw BE. Ceftazidime as monotherapy or combined with teicoplanin for initial empiric treatment for presumed bacteremia in febrile granulocytopenic patients. Antimicrob Agents Chemother 1991, 35, 672-678.
8. Rubin M, Hathorn JW, Marshall D, Gress J, Streinberg SM, Pizzo PA. Gram-positive infections and the use of vancomycin in 550 episodes of fever and neutropenia. Ann Intern Med 1988, 108, 30-35.
9. Schwalbe RS, Stapleton JT, Gilligan PH. Emergence of vancomycin resistance in coagulase-negative staphylococci. N Engl J Med 1987, 316, 927-931.
10. Frieden TR, Munsiff SS, Low DE, et al. Emergence of vancomycin-resistant enterococci in New York City. Lancet 1993, 342, 76-79.
11. De Pauw BE, Donnelly JP, Elves A, Verhagen C, Nováková IRO, Van der Meer JWM. Towards individually tailored empiric antibiotic therapy in febrile granulocytopenic patients. Neth J Med 1990, 37, 111-119.
12. De Pauw BE, Deresinski SC, Feld R, Lane-Allman EF, Donnelly JP. Ceftazidime compared with piperacillin and tobramycin for the empiric treatment of fever in neutropenic patients with cancer. A multicenter randomized trial. Ann Intern Med 1994, 120, 834-844.
13. Nováková IRO, Donnelly JP, De Pauw BE. Potential sites of infection that develop in febrile neutropenic patients. Leukemia Lymphoma 1993, 10, 461-467.
14. Arning M, Gehrt A, Aul C, Runde V, Hadding U, Schneider W. Septicemia due to Streptococcus mitis in neutropenic patients with acute leukemia. Blut 1990, 61, 364-368.
15. Dompeling EC, Donnelly JP, Raemaekers JMM, De Pauw BE. Pre-emptive administration of corticosteroids prevents the development of ARDS associated with Streptococcus mitis bacteremia following chemotherapy with high-dose cytarabine. Ann Hematol 1994, 69, 69-71.
16. Patel R, Cockerill FR, Porayko MK, Osmon DR, Ilstrup DM, Keating MR. Lactobacillemia in liver transplant patients. Clin Infect Dis 1993, 18, 207-212.
17. Nováková IRO, Donnelly JP, Verhagen CS, De Pauw BE. Teicoplanin as modification of initial empirical therapy in febrile granulocytopenic patients. J Antimicrob Chemother 1990, 25, 985-993.